EQL Pharma Investor Relations

Welcome to EQL Pharma's Investor Pages!

We strive to have an open and proactive dialogue with our shareholders.
Read More

"Our portfolio grows from 26 to 28 products"

Listen to CEO Axel Schörling present EQL Pharma's latest report (in Swedish)
Interim Report Q2 2023/2024

Press Releases

Se all

EQL Pharma in Short

EQL Pharma is an entrepreneurial pharmaceutical company focusing on simplicity and efficiency at all levels of the value chain in order to be able to deliver cost-efficient medicines of highest quality to pharmacies and hospitals.
Read more about us

Financial Calendar


Interim Report Q3


Year End Report Q4